Feed aggregator

AbbVie Ends I-Mab Deal for CD47 Antibody Compounds, Products

Biospace news - Mon, 09/25/2023 - 02:00
AbbVie Ends I-Mab Deal for CD47 Antibody Compounds, Products 9/25/2023

Merck, Eisai Post Back-to-Back Phase III NSCLC Failures for Keytruda-Lenvima Combo

Biospace news - Mon, 09/25/2023 - 02:00
Merck, Eisai Post Back-to-Back Phase III NSCLC Failures for Keytruda-Lenvima Combo 9/25/2023

Morphic’s Ulcerative Colitis Pill Misses Expectations in Mid-Stage Study, Stock Falls

Biospace news - Mon, 09/25/2023 - 02:00
Morphic’s Ulcerative Colitis Pill Misses Expectations in Mid-Stage Study, Stock Falls 9/25/2023

African Green Monkeys Play Key Role in Advancing Preclinical Research Amid Supply Chain Shortage

Biospace news - Mon, 09/25/2023 - 02:00
African Green Monkeys Play Key Role in Advancing Preclinical Research Amid Supply Chain Shortage 9/25/2023

Upcoming NurOwn Adcomm Highlights Regulatory Role for Patient Advocates

Biospace news - Mon, 09/25/2023 - 02:00
Upcoming NurOwn Adcomm Highlights Regulatory Role for Patient Advocates 9/25/2023

FDA Regulatory Gauntlet Isn’t Getting Any Easier, Just Ask These Companies

Biospace news - Fri, 09/22/2023 - 02:00
FDA Regulatory Gauntlet Isn’t Getting Any Easier, Just Ask These Companies 9/22/2023

AstraZeneca, Daiichi Tout Phase III Breast Cancer Data in Challenge to Gilead

Biospace news - Fri, 09/22/2023 - 02:00
AstraZeneca, Daiichi Tout Phase III Breast Cancer Data in Challenge to Gilead 9/22/2023

Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo

Biospace news - Fri, 09/22/2023 - 02:00
Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo 9/22/2023

Intarcia’s Diabetes Drug-Device Implant Unanimously Rejected by Adcomm

Biospace news - Fri, 09/22/2023 - 02:00
Intarcia’s Diabetes Drug-Device Implant Unanimously Rejected by Adcomm 9/22/2023

10 Promising Therapies for Hard-to-Treat Cancers

Biospace news - Fri, 09/22/2023 - 02:00
10 Promising Therapies for Hard-to-Treat Cancers 9/22/2023

Roche Claims Another Legal Victory Over Takeda in Hemophilia Patent Case

Biospace news - Fri, 09/22/2023 - 02:00
Roche Claims Another Legal Victory Over Takeda in Hemophilia Patent Case 9/22/2023

Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

Biospace news - Wed, 09/20/2023 - 02:00
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans 9/20/2023

5 Life Sciences IPOs in 2023—and the Future Forecast

Biospace news - Wed, 09/20/2023 - 02:00
5 Life Sciences IPOs in 2023—and the Future Forecast 9/20/2023

Novartis Returns Cancer Asset Tislelizumab to BeiGene

Biospace news - Tue, 09/19/2023 - 02:00
Novartis Returns Cancer Asset Tislelizumab to BeiGene 9/19/2023

Astellas Touts Izervay Phase III Geographic Atrophy Data, Eyes Label Expansion

Biospace news - Tue, 09/19/2023 - 02:00
Astellas Touts Izervay Phase III Geographic Atrophy Data, Eyes Label Expansion 9/19/2023

FDA Accepts Orchard’s BLA for Rare Disease Gene Therapy Behind EU Approval

Biospace news - Tue, 09/19/2023 - 02:00
FDA Accepts Orchard’s BLA for Rare Disease Gene Therapy Behind EU Approval 9/19/2023

Sanofi Sells 11 CNS Assets to Pharmanovia including Frisium and Gardenal

Biospace news - Tue, 09/19/2023 - 02:00
Sanofi Sells 11 CNS Assets to Pharmanovia including Frisium and Gardenal 9/19/2023

The First Annual BioTechX USA: Blending Science and Technology

Biospace news - Tue, 09/19/2023 - 02:00
The First Annual BioTechX USA: Blending Science and Technology 9/19/2023

Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?

Biospace news - Fri, 09/15/2023 - 02:00
Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery? 9/15/2023

RayzeBio’s $311M, Neumora’s $250M IPOs Among Biotech’s Largest This Year

Biospace news - Fri, 09/15/2023 - 02:00
RayzeBio’s $311M, Neumora’s $250M IPOs Among Biotech’s Largest This Year 9/15/2023